Dorothee Wernicke
- Cancer Research top 0.5%
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 2
- Molecular Biology top 5%
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
- Immunology top 5%
- T-cell and Retrovirus Studies 2
-
- Growth Hormone and Insulin-like Growth Factors 2
- Virology top 10%
- HIV Research and Treatment 2
-
- Virus-based gene therapy research 2
- Co-authors
- Carlo M. CroceMario AcunzoGiulia RomanoHansjüerg AlderFrancesca LovatNicola ZanesiEugenio GaudioMichael A. Caligiuri
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (4 papers)Nucleic Acids Research (1 paper)
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Dorothee Wernicke
12 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 1.7k
- Molecular Biology 2.0k
- Immunology 463
- Endocrinology, Diabetes and Metabolism 232
- Virology 46
Countries citing papers authored by Dorothee Wernicke
This map shows the geographic impact of Dorothee Wernicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothee Wernicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothee Wernicke more than expected).
Fields of papers citing papers by Dorothee Wernicke
This network shows the impact of papers produced by Dorothee Wernicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothee Wernicke. The network helps show where Dorothee Wernicke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dorothee Wernicke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 37 | |
| 2 | 2015 | 57 | |
| 3 | MicroRNA and cancer – A brief overviewbreakdown → | 2014 | 520 |
| 4 | 2014 | 12 | |
| 5 | 2013 | 151 | |
| 6 | MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responsebreakdown → | 2012 | 1284 |
| 7 | 2011 | 199 | |
| 8 | Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. | 1993 | 211 |
| 9 | Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. | 1992 | 163 |
| 10 | 1986 | 10 | |
| 11 | 1983 | 96 | |
| 12 | 1981 | 3 |
About Dorothee Wernicke
Dorothee Wernicke is a scholar working on Virology, Cancer Research and Immunology, having authored 12 papers that have together received 2.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (2 papers), T-cell and Retrovirus Studies (2 papers), Virus-based gene therapy research (2 papers), HIV Research and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.0k citations) and Immunology (463 citations). Dorothee Wernicke has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Carlo M. Croce, Mario Acunzo, Giulia Romano, Hansjüerg Alder, Francesca Lovat, Nicola Zanesi, Eugenio Gaudio, Michael A. Caligiuri, Melissa Crawford and Alessio Paone. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.